AGX
- NYSE - MATERIALS & CONSTRUCTION - Heavy Construction
Argan Inc
|
$28.18 |
+0.41
1.48%
|
$28.80
|
$27.78
|
1.44% |
83,097 105.86%
|
78,500
|
Most Recent Note for AGX - 1/7/2014 12:19:52 PM
Hitting another new 52-week high with today's 2nd consecutive volume-driven gain. Reported earnings +93% on -15% sales for the Oct '13 quarter. Held its ground and rallied since noted with caution in the 12/09/13 mid-day report - "Reported earnings +98% on -30% sales for the Jul '13 quarter. The Building -Heavy Construction firm is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ALGN
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Align Technology Inc
|
$61.78 |
+1.88
3.14%
|
$61.98
|
$61.09
|
1.13% |
913,485 109.36%
|
835,300
|
Most Recent Note for ALGN - 1/7/2014 12:18:51 PM
Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Today's 3rd consecutive gain with higher volume has it rallying to new 52-week highs after holding its ground near its 50 DMA line in recent weeks. Prior mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AMBA
- NASDAQ - ELECTRONICS - Semiconductor - Specialized
Ambarella Inc
|
$35.35 |
+1.29
3.79%
|
$36.49
|
$35.02
|
0.94% |
1,120,524 104.82%
|
1,069,000
|
Most Recent Note for AMBA - 1/7/2014 12:20:49 PM
Hitting another new 52-week high today while adding to an impressive streak of volume-driven gains. Prior mid-day reports cautioned - "Reported earnings +23% on +29% sales revenues for the Oct '13 quarter, a 2nd consecutive quarter below the +25% minimum earnings guideline (C criteria). Found support at its 200 DMA line during its consolidation after violating prior lows near $15.50 when dropped from the Featured Stocks list on 8/21/13."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BABY
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Natus Medical Inc
|
$24.15 |
-0.11 -0.45%
|
$25.58
|
$24.66
|
-2.06% |
371,028 94.84%
|
391,200
|
Most Recent Note for BABY - 1/7/2014 12:23:08 PM
Reversed into the red after spiking to another new 52-week high today following a big volume-driven gain on the prior session. Held its ground stubbornly and made gradual progress since its considerable "breakaway gap" on 10/24/13. Prior mid-day reports repeatedly cautioned members - "The 5 latest quarterly comparisons through Sep '13 showed earnings increases above the +25% minimum guideline (C criteria). Its up and down annual earnings (A criteria) history is cause for concern. It survived but failed to impress since dropped from the Featured Stocks list on 10/07/08."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BEAV
- NASDAQ - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
B/E Aerospace Inc
|
$82.99 |
+0.18
0.22%
|
$83.88
|
$88.43
|
-6.15% |
842,973 85.17%
|
989,800
|
Most Recent Note for BEAV - 1/7/2014 12:25:14 PM
Holding its ground today after violating its 50 DMA line with a volume-driven loss on the prior session. Reported earnings +16% on +16% sales revenues for the Sep '13 quarter. Last noted in the 10/23/13 mid-day report with caution - "Rebounded promptly after violating its 50 DMA line in recent weeks. Reported +24% earnings on +11% sales revenues for the quarter ended June 30, 2013 versus the year ago period, marking its 4th consecutive quarterly comparison just below the +25% minimum earnings guideline (C criteria). A downturn in FY '09 earnings is a flaw with respect to the A criteria of the investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CBZ
- NYSE - Comml Svcs-Consulting
C B I Z Inc
|
$9.16 |
+0.22
2.44%
|
$9.29
|
$9.40
|
-2.57% |
1,880,765 455.39%
|
413,000
|
Most Recent Note for CBZ - 1/7/2014 12:25:42 PM
Reported earnings +56% on +13% sales revenues for the Sep '13 quarter but fundamental concerns remain. Found support at its 200 DMA line during its consolidation then rallied to new highs since the 7/30/13 mid-day report cautioned members - "Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria). Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CW
- NYSE - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
Curtiss-Wright Corp
|
$62.85 |
+2.39
3.95%
|
$63.11
|
$62.92
|
-0.12% |
249,439 85.57%
|
291,500
|
Most Recent Note for CW - 1/7/2014 12:26:52 PM
Hitting another new 52-week high after gapping up today. Held its ground stubbornly following a streak of volume-driven gains, and it is very extended from any sound base. Fundamentals are not a match with winning models of the fact-based system although recent quarterly comparisons through Sep '13 showed better sales revenues and earnings increases. It survived but failed to impress since long ago noted in the 10/26/07 mid-day report - "Its earnings and sales growth history are below guidelines. Recently rallied above its prior 2007 high in the $49 area."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FONR
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Fonar Corp
|
$25.63 |
+1.64
6.84%
|
$25.83
|
$24.09
|
6.39% |
536,181 165.03%
|
324,900
|
Most Recent Note for FONR - 1/7/2014 12:28:03 PM
Posting a 2nd considerable volume-driven gain in a row for a new 52-week high. Found support above its 50 DMA line during its deep consolidation since noted in the 11/25/13 mid-day report with caution - "Reported strong sales revenues and earnings increases in the Jun and Sep '13 quarters, but its prior quarterly and annual earnings (C and A criteria) history is not a good match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FUL
- NYSE - CHEMICALS - Specialty Chemicals
Fuller H B Co
|
$51.69 |
+0.32
0.62%
|
$51.87
|
$52.70
|
-1.92% |
354,854 175.24%
|
202,500
|
Most Recent Note for FUL - 1/7/2014 12:29:39 PM
Making its 4th consecutive mid-day report appearance while hovering at its 52-week high after finding recent support near its 50 DMA line. Prior reports cautioned members - "Quarterly earnings comparisons through Aug '13 versus year ago periods were not strong and steady above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has steadily improved since a downturn in FY '08."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IILG
- NASDAQ - Leisure-Services
Interval Leisure Group
|
$30.60 |
+0.21
0.69%
|
$30.77
|
$32.13
|
-4.76% |
238,841 115.49%
|
206,800
|
Most Recent Note for IILG - 1/7/2014 12:31:29 PM
Making its 2nd consecutive mid-day report appearance. The 1/06/14 mid-day report cautioned members - "Consolidating near its 52-week high, enduring distributional pressure while extended from any sound base pattern. Reported strong quarterly earnings increases but sales revenues growth has been sub par. Annual earnings (A criteria) history has not been strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MANH
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Technical & System Software
Manhattan Associates Inc
|
$123.25 |
-0.80 -0.64%
|
$125.57
|
$126.27
|
-2.39% |
89,315 89.05%
|
100,300
|
Most Recent Note for MANH - 1/7/2014 12:35:41 PM
Perched at its 52-week high today following a volume-driven gain, however it did not form a sound base since last noted with caution in the 10/23/13 mid-day report - "Reported earnings +40% on +12% sales revenues for the quarter ended Sep 30, 2013 versus the year ago period. Encouraging earnings acceleration above the +25% minimum earnings guideline helps satisfy the C criteria, however sales revenues growth has only been in the +6-12% range. After a downturn in its FY '09 earnings (A criteria) it has shown strong earnings growth."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MGIC
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Magic Software Enter Ltd
|
$7.46 |
+0.06
0.81%
|
$7.53
|
$7.54
|
-1.06% |
51,431 92.17%
|
55,800
|
Most Recent Note for MGIC - 1/7/2014 12:37:15 PM
Hitting new 52-week highs with above average volume behind its latest gains. The 1/06/14 mid-day report cautioned members - "This Israel-based Computer - Tech Services firm's quarterly earnings history has been below the +25% minimum guideline (C criteria) but improved in the Sep '13 quarter. It has a strong annual earnings (A criteria) history. Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PACR
- NASDAQ - TRANSPORTATION - Air Delivery & Freight Service
Pacer International Inc
|
$8.97 |
-0.02 -0.22%
|
$9.00
|
$9.23
|
-2.82% |
643,490 159.87%
|
402,500
|
Most Recent Note for PACR - 1/7/2014 12:37:50 PM
Gapped up on the prior session, rallying within close striking distance of its 52-week high after finding support near its 50 DMA line recently. Fundamental concerns remain. Prior mid-day reports cautioned members - "Sales and earnings history below guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TARO
- NYSE - DRUGS - Drug Manufacturers - Other
Taro Pharmaceutical Inds
|
$102.65 |
+0.91
0.89%
|
$103.09
|
$101.74
|
0.89% |
25,131 121.41%
|
20,700
|
Most Recent Note for TARO - 1/7/2014 12:41:54 PM
Inching to new 52-week highs and stubbornly holding its ground while tallying small volume-driven gains. Prior mid-day reports cautioned members - . Reported earnings +47% on +28% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Reported earnings -6% on -4% sales revenues for the Jun '13 quarter, below the +25% minimum guideline (C criteria). The Israel-based Medical - Generic Drugs firm faced no resistance due to overhead supply when noted in prior mid-day reports with caution. The number of top-rated funds owning its shares from 2 in Mar '12 to 23 as of Jun '13, a reassuring sign concerning the I criteria."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VRTU
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Information Technology Service
Virtusa Corp
|
$35.47 |
-1.95 -5.20%
|
$36.58
|
$38.49
|
-7.86% |
104,974 93.31%
|
112,500
|
Most Recent Note for VRTU - 1/7/2014 12:43:52 PM
Retreating from its 52-week and all-time highs, testing support at its 50 DMA line today after proposing a new Public Offering. Last noted in the 12/16/13 mid-day report with caution - "Reported earnings +22% on +17% sales revenues for the Sep '13 quarter, below the +25% minimum guideline (C criteria) for a 2nd consecutive quarterly comparison. Not a match with the models of past great winners. Annual earnings (A criteria) history has been improving since a downturn in FY '09."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|